MedDataX Logo

The Serotonergic Transmitter System in Dementia and Affective Disorders

NCT ID: NCT00192998

Last Updated: 2007-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography \[PET\]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mood Disorders Alzheimer Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Affective disorder Alzheimer dementia healthy controls

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Moderate to severe Alzheimer's disease
* Individuals genetically predisposed to affective disorder
* Healthy gender and age matched controls

Exclusion Criteria

* Contraindications to magnetic resonance imaging (MRI)
* Use of psychoactive drugs
* Past or present affective disorder
* Other systemic diseases that may affect brain function
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vibe G. Frokjaer, MD

Role: PRINCIPAL_INVESTIGATOR

Neurobiological Research Unit, Copenhagen University Hospital, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Neurobiological Research Unit

Copenhagen, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vibe G. Frokjaer, MD

Role: CONTACT

Phone: +45 3545 6714

Email: [email protected]

Steen G. Hasselbalch, MD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vibe G. Frokjaer, MD

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

http://www.nru.dk

homepage for the neurobiological research unit, Copenhagen, Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SERT-AD

Identifier Type: -

Identifier Source: org_study_id